Article
Convergent evolutionary analysis identifies significant mutations in drug resistance targets of Mycobacterium tuberculosis.
Antimicrobial agents and chemotherapy - 1 Sept 2008
Hazbón Manzour Hernando, Motiwala Alifiya S, Cavatore Magali, Brimacombe Michael, Whittam Thomas S, Alland David
Abstract excerpt
Mycobacterium tuberculosis adapts to the environment by selecting for advantageous single-nucleotide polymorphisms (SNPs). We studied whether advantageous SNPs could be distinguished from neutral mutations within genes associated with drug resistance. A total of 1,003 clinical isolates of M. tuberculosis were related phylogenetically and tested for the distribution of SNPs in putative drug resistance genes. Drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
